BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Wilms Tumor

Below is an extended Wilms Tumor research listing. Click here to return to the Wilms Tumor main in depth entry.

Recent Publications on Wilms Tumor:

SF-1 is a Diagnostically Useful Immunohistochemical Marker and Comparable to Other Sex Cord-Stromal Tumor Markers for the Differential Diagnosis of Ovarian Sertoli Cell Tumor.
Immunohistochemistry can be an important part of the diagnosis of Sertoli...
Direct Link
30th August, 2008
Department of Pathology, Magee-Womens Hospital (C.Z., K.M., D.D.),
Brain-derived neurotrophic factor and obesity in the WAGR syndrome.
BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been found to be...
Direct Link
30th August, 2008
Unit on Growth and Obesity, Program in Developmental Endocrinology and
Analysis of Cox-2 expression in Wilms' tumor.
Cylooxygenase-2 (Cox-2) inhibitors have increasingly become therapeutic...
Direct Link
30th August, 2008
Department of Pathology and Laboratory Medicine, Pathology Section, Parma
The Wilms' tumor suppressor WT1 inhibits malignant progression of neoplastigenic mammary epithelial cells. 30th August, 2008
Department of Surgery, Creighton University Medical School, Omaha, NE
Expression of Pax8 as a Useful Marker in Distinguishing Ovarian Carcinomas From Mammary Carcinomas.
The ovary is a common site of involvement for metastasis and the breast is...
Direct Link
30th August, 2008
*Department of Pathology, New York University School of Medicine
Adult Wilms Tumor During Gestational Period.
The ovary is a common site of involvement for metastasis and the breast is...
Direct Link
30th August, 2008
Hospital Universitario de Brasilia, Universidade de Brasilia, Brasilia,
Wilms' tumor gene 1 (WT1) overexpression in neurons in deep endometriosis: a pilot study.
Innervation of deep endometriosis has recently been linked to its severe...
Direct Link
30th August, 2008
Experimental Laboratory of Gynaecology, Department of Obstetrics and
[Anti-mullerian hormone in young women after chemotherapy and infradiaphragmatic radiotherapy for childhood cancer.] 30th August, 2008
Mutational Analysis of WTX Gene in Wnt/ beta-Catenin Pathway in Gastric, Colorectal, and Hepatocellular Carcinomas.
A recent study of Wilms' tumors discovered a new X chromosome gene, Wilms'...
Direct Link
23rd August, 2008
Department of Pathology, College of Medicine, The Catholic University of
Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance via Down-Regulation of Estrogen Receptor-{alpha} Expression in Breast Cancer Cells.
The antiestrogen tamoxifen has been used in the treatment of...
Direct Link
19th August, 2008
Princess Margaret Hospital/Ontario Cancer Institute, University Health
Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy.
PURPOSE: Evaluation of dosimetric benefits of advanced radiotherapy...
Direct Link
12th August, 2008
Department of Radiotherapy and Radiobiology, AKH Vienna, Medical
Vertical transmission of a mutation in exon 1 of the WT1 gene: Lessons for genetic counseling.
We present a vertical transmission of a nonsense mutation in exon 1 of the...
Direct Link
9th August, 2008
Medical Genetics Institute, Assaf Harofeh Medical Center, Zerifin, Israel.
Pediatric liver tumors - a pictorial review.
Hepatic masses constitute about 5-6% of all intra-abdominal masses in...
Direct Link
7th August, 2008
Department of Radiology, University of California, San Francisco, 505
The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.
Compelling evidences indicate a key role for regulatory T cells (T(reg))...
Direct Link
5th August, 2008
Tumor Immunology Section, King Faisal Specialist Hospital and Research
Wilms' tumor-1: a riddle wrapped in a mystery, inside a kidney.
After more than 15 years of intense study, WT1 remains a complex protein...
Direct Link
2nd August, 2008
Department of Medicine, Children's Hospital Boston, Boston, Massachusetts
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional